Affinage

GLDN

Gliomedin · UniProt Q6ZMI3

Length
551 aa
Mass
59.0 kDa
Annotated
2026-06-10
12 papers in source corpus 3 papers cited in narrative 3 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

Gliomedin (GLDN) is a cell-surface adhesion molecule that organizes the nodes of Ranvier by mediating axoglial contact required for the initial clustering of Na+ channels at developing nodes (PMID:27616481). It localizes to the cell surface and directly binds the axonal protein neurofascin-186 (NF186); biallelic loss-of-function mutations abolish both this surface localization and the NF186 interaction, and ultrastructural analysis of patient sciatic nerve reveals marked node-lengthening defects (PMID:27616481). Patient-derived missense variants impair gliomedin function and produce defects consistent with fetal akinesia, establishing GLDN loss as a cause of lethal arthrogryposis multiplex congenita (PMID:27616481, PMID:32812332). Beyond its nodal role, GLDN marks a population of odontogenic stem cells in the dental papilla, where it sustains their self-renewal, migratory, and odontogenic differentiation capacity through autocrine and paracrine BMP5 signaling, enabling regeneration of vascularized dental pulp (PMID:41760598).

Mechanistic history

Synthesis pass · year-by-year structured walk · 3 steps
  1. 2016 High

    Established that GLDN functions as a surface adhesion molecule whose binding to axonal NF186 is required to initiate Na+ channel clustering at nodes of Ranvier, and that human loss-of-function disrupts this in disease.

    Evidence Cell-based localization and NF186 co-interaction assays, TEM of human sciatic nerve, and exome/linkage analysis across four unrelated families

    PMID:27616481

    Open questions at the time
    • Does not resolve the structural basis of the GLDN-NF186 interaction
    • Does not define how surface localization is regulated
    • Mechanism linking nodal disruption to arthrogryposis phenotype not detailed
  2. 2020 Medium

    Extended the genotype-phenotype link by showing that specific patient missense variants impair gliomedin function, supporting pathogenicity in arthrogryposis multiplex congenita and a fetal akinesia mechanism.

    Evidence Cell-based functional assays of multiple patient-derived GLDN variants including p.Leu365Phe and p.Arg393Lys

    PMID:32812332

    Open questions at the time
    • Limited mechanistic detail on how each variant impairs function
    • Single study without independent replication of variant-level effects
  3. 2026 Medium

    Revealed a function for GLDN outside the nervous system, defining it as a marker and effector of odontogenic stem cell identity acting through BMP5 signaling.

    Evidence Single-cell sequencing, in vitro self-renewal/migration/differentiation/tube-formation assays, and in vivo ectopic dental pulp regeneration with mechanistic analysis of BMP5

    PMID:41760598

    Open questions at the time
    • Direct molecular link between GLDN and BMP5 signaling not biochemically resolved
    • Single-lab finding for the BMP5 pathway placement
    • Relationship between nodal adhesion role and stem cell role unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How GLDN's adhesion-mediated nodal function mechanistically connects to its role in BMP5-dependent stem cell maintenance remains unresolved.
  • No structural model of GLDN domains or its NF186 interface
  • Mechanism by which GLDN engages BMP5 signaling not defined
  • No unifying model across neural and dental contexts

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098631 cell adhesion mediator activity 1
Localization
GO:0005576 extracellular region 1 GO:0005886 plasma membrane 1
Pathway
R-HSA-112316 Neuronal System 1
Partners

Evidence

Reading pass · 3 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2016 Biallelic loss-of-function mutations in GLDN abolish cell surface localization of gliomedin and disrupt its interaction with its axonal partner neurofascin-186 (NF186), as demonstrated in a cell-based assay. This axoglial contact between gliomedin and NF186 is essential for the initial clustering of Na+ channels at developing nodes of Ranvier. Transmission electron microscopy of sciatic nerve from an affected individual confirmed marked lengthening defects of the nodes. Cell-based localization assay, co-interaction assay with NF186, transmission electron microscopy of human sciatic nerve, exome sequencing/linkage analysis in human families American journal of human genetics High 27616481
2020 Functional assays of GLDN patient variants (including novel p.Leu365Phe and p.Arg393Lys) demonstrated that specific missense mutations impair gliomedin function, supporting their pathogenicity in arthrogryposis multiplex congenita. Experimental data confirmed that loss of gliomedin function leads to defects consistent with fetal akinesia. Functional variant assays (cell-based) for multiple patient-derived GLDN variants American journal of medical genetics. Part A Medium 32812332
2026 GLDN is essential for maintaining the phenotype and function of GLDN+ odontogenic stem cells (OSCs) in the dental papilla through BMP5 signaling via autocrine and paracrine mechanisms. GLDN+ OSCs exhibit enhanced self-renewal, migratory capacity, odontogenic differentiation, and ability to induce endothelial cell migration and tube formation compared to GLDN- DPSCs. In vivo ectopic transplantation confirmed that GLDN+ OSCs can regenerate vascularized dental pulp with an odontoblast layer. Single-cell sequencing, in vitro functional assays (self-renewal, migration, differentiation, tube formation), in vivo ectopic dental pulp regeneration model, mechanistic analysis of BMP5 signaling International journal of oral science Medium 41760598

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2009 Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension 279 19262477
2009 Flavobacterium johnsoniae gldN and gldO are partially redundant genes required for gliding motility and surface localization of SprB. Journal of bacteriology 55 20038590
2016 Mutations in GLDN, Encoding Gliomedin, a Critical Component of the Nodes of Ranvier, Are Responsible for Lethal Arthrogryposis. American journal of human genetics 45 27616481
2015 Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. Journal of hypertension 26 26066644
2020 Cytophaga hutchinsonii gldN, Encoding a Core Component of the Type IX Secretion System, Is Essential for Ion Assimilation, Cellulose Degradation, and Cell Motility. Applied and environmental microbiology 21 32245758
2017 Survival among children with "Lethal" congenital contracture syndrome 11 caused by novel mutations in the gliomedin gene (GLDN). Human mutation 20 28726266
2003 Identification and characterization of CRG-L2, a new marker for liver tumor development. Oncogene 16 12642876
2018 The ColM Family, Polymorphic Toxins Breaching the Bacterial Cell Wall. mBio 14 29440573
2014 Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability. Hypertension research : official journal of the Japanese Society of Hypertension 14 25253582
2020 The latest FADS: Functional analysis of GLDN patient variants and classification of GLDN-associated AMC as a type of viable fetal akinesia deformation sequence. American journal of medical genetics. Part A 8 32812332
2026 Identification of GLDN+ odontogenic stem cells as crucial for human tooth development and regeneration. International journal of oral science 0 41760598
2026 Anti-GLDN antibody-associated CIDP (nodopathy): transient IVIg response and B-cell depletion remission. BMC neurology 0 42151911

Missed literature

Know a paper Affinage missed for GLDN? Flag it for the maintainers and the community.

No submissions yet.